Itepekimab was compared to placebo in a RCT for use in patie…

Itepekimab was compared to placebo in a RCT for use in patients with moderate-to-severe atopic dermatitis (i.e. severe skin inflammation and itching). The primary outcome was changes in the Eczema Area and Severity Index (EASI) score which has a minimally clinically important difference of a change in at least 6.6 points. At week 16 in the RCT, itepekimab had a mean decrease in the EASI score of 14.2 points compared to placebo (p=0.12).

It is estimated that angioedema occurs in approximately 0.1%…

It is estimated that angioedema occurs in approximately 0.1% of patients taking losartan. An investigator would like to identify potential risk factors for patients who experience angioedema while taking losartan. Which of the following study designs would be most appropriate?

A new antihistamine, metalazine, is compared to placebo for…

A new antihistamine, metalazine, is compared to placebo for mild-to-moderate seasonal allergies. An allergy symptom visual analog scale of 0, meaning no symptoms, to 10, meaning the worst symptoms imaginable is used as the primary outcome. Metalazine was found to decrease the allergy symptoms visual analog scale by 3.2 points (95%CI -0.4 to 7.8). Which of the following statements best describes the potential type of statistical error present in this study?

A study compares is determining the impact of daily consumpt…

A study compares is determining the impact of daily consumption of green tea on systolic blood pressure. Among patients who began drinking green tea daily (n=23) the systolic blood pressure decreased by a mean of 5 mmHg and among patients with no dietary change (n=32) the systolic blood pressure decreased by a mean of 1 mmHg. Which of the following tests would be most appropriate to determine if the results are statistically significantly different?